Showing 2351-2360 of 2735 results for "".
- IT Cosmetics Launches Confidence at Work Initiativehttps://modernaesthetics.com/news/it-cosmetics-launches-confidence-at-work-initiative/2473247/IT Cosmetics is launching Confidence at Work, an initiative that aims to bring awareness to the confidence crisis affecting women at work. The Founder of The American Confidence Institute, Alyssa Dver, will serve as the brand's official Confidence Educator.
- Apyx Medical Corporation Scores FDA 510(k) Clearance for Renuvion Handpiecehttps://modernaesthetics.com/news/apyx-medical-corporation-scores-fda-510k-clearance-for-renuvion-handpiece/2473245/The U.S. Food and Drug Administration has granted marketing clearance to Apyx Medical Corporation’s Renuvion Dermal Handpiece for specific dermal resurfacing procedures. The Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to
- Colorescience Finishing Touch Protocol Boosts Patient Satisfaction after Microneedling RFhttps://modernaesthetics.com/news/colorescience-finishing-touch-protocol-boosts-patient-satisfaction-after-microneedling-rf/2473243/Colorescience’s Finishing Touch post-treatment skincare protocol improves patient confidence, comfort, satisfaction, and increases the likelihood of a repeat radiofrequency microneedling procedure, according to research in The Journal of Clinical and Aesthetic Dermatology
- Evolus Celebrates Third Anniversary of the Launch of Jeuveauhttps://modernaesthetics.com/news/evolus-celebrates-third-anniversary-of-the-launch-of-jeuveau/2473239/Evolus, Inc. is celebrating the three-year anniversary of the launch of its flagship neurotoxin product, Jeuveau (prabotulinumtoxinA-xvfs), the first neurotoxin dedicated exclusively to aesthetics. Jeuveau is used for the temporary improvement in the appearance of moderate to severe ve
- New Ophthalmologist-Created Eye Skincare Line Launcheshttps://modernaesthetics.com/news/new-ophthalmologist-created-eye-skincare-line-launches/2473236/Now available for pre-order, Daily Practice, the new eye care line by Ashley Brissette, MD, has launched with a hero product—Eye Revive. Having worked as an ophthalmologist for six years, New York City-based Dr. Brissette says she recognized a grow
- Coming This Week: Cutera AviClear Webinarhttps://modernaesthetics.com/news/coming-this-week-cutera-aviclear-webinar/2473230/Cutera hosts the first webinar for AviClear, the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, this week. Dermatologists Jeffrey S. Dover, MD, FRCPC and Julie C. Harper, MD will discuss the latest advancement in the treatment of acn
- Elevai Labs Names Chief Marketing and Brand Advisorhttps://modernaesthetics.com/news/elevai-labs-names-chief-marketing-and-brand-advisor/2473228/Brenda Buechler is now Chief Marketing and Brand Advisor for Elevai Labs, Inc. Elevai is a science-based aesthetic skincare company providing topical formulations featuring by ethically sourced, human umbilical mesenchymal stem cells (hUMSC)-derived e
- New from Lumenis: triLift Targets Three Elements of Aginghttps://modernaesthetics.com/news/new-form-lumenis-trilift-targets-three-elements-of-aging/2473227/Lumenis Be, Ltd., has launched triLift, a facial stimulation device targeting three aging elements—structure, contour, and texture—by treating the three tissue layers. The device affects the muscl
- Cutera Invites ASLMS Attendees to Celebrate AviClear Launchhttps://modernaesthetics.com/news/cutera-invites-aslms-attendees-to-celebrate-aviclear-launch/2473222/Cutera is celebrating the launch of AviClear during the ASLMS meeting in San Diego, and meeting attendees are invited to join the festivities. AviClear is the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, The AviClear laun
- Study: Skin of Color Patients Are Under-represented in Cosmetic Clinical Trialshttps://modernaesthetics.com/news/study-skin-of-color-patients-are-under-represented-in-cosmetic-clinical-trials/2473221/There’s a lack of ethnic/racial diversity in industry-sponsored aesthetic trials, according to new research in the April 2022 issue of Lasers in Surgery and Medicine. Researchers, led by Lisa Akintilo MD, MPH a current PGY-4 dermatology resident at New York